Position in RPRX
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$5,326
+$2,208 QoQ
Shares Held
95
+46.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#60
of 65 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Dogwood Wealth Management LLC holds $110,687 across 22 Biotechnology names. RPRX ranks #5 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
50 | $24,836 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32 | $19,953 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
30 | $9,030 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
39 | $7,303 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
95 | $5,326 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
9 | $4,832 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
59 | $4,809 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
80 | $4,363 |
All Filings in RPRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,326 | 95 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $3,118 | 65 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $811 | 21 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $141 | 4 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||